Profound Therapeutics
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.profoundtx.comRevenue
<$5 MillionIndustry
About Profound Therapeutics
Profound Therapeutics Org Chart
Is Profound Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Profound Therapeutics has new funding data
Check out if Profound Therapeutics is spiking on competitors!
Earning: See what the market has to say on Profound Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Profound Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Profound Therapeutics
Website visits: Recent activity has been detected on your website
Click to see if Profound Therapeutics had a recent Job posting/layoffs
Profound Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Profound Therapeutics launches new products
Recommended Actions
Find VP level buyers at Profound Therapeutics
Find 2 more new buyers
Compare Similar Companies to Profound Therapeutics
Compare insights from companies similar to Profound Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Profound Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Profound Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Profound Therapeutics.
Profound Therapeutics Tech Stack
A closer look at the technologies used by Profound Therapeutics
Most Recent Scoops
Profound Therapeutics News & Media
ProFound Therapeutics Announces Multi-Year Strategic Collaboration with Novartis to Discover and Develop Novel Therapeutics for Cardiovascular Disease
ProFound to receive $25M in upfront and near-term milestone payments with a potential value from downstream milestones of $750M per targetProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded human proteome and using its newfound insights to unlock a universe of potential new medicines, today announced the appointment of Klaus Urbahns, Ph.D., as Chief Scientific Officer. Urbahns will lead the Company’s platform and drug discovery and development efforts to advance first-in-class therapeutics leveraging the company’s ProFoundry™ Platform. Urbahns brings three decades of
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Profound Therapeutics
Profound Therapeutics's team is creating profound impacts on Profound Therapeutics's understanding of biology and disease and Profound Therapeutics's ability to create therapeutics that would not have previously been possible.... Read More

